Westwood, MA, United States of America

Christopher A Hobson

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher A. Hobson: Innovator in Transdermal Delivery Systems

Introduction

Christopher A. Hobson is a notable inventor based in Westwood, MA (US). He has made significant contributions to the field of transdermal delivery systems, focusing on innovative methods to enhance therapeutic applications. His work is characterized by a commitment to improving patient care through advanced technology.

Latest Patents

Hobson holds a patent for "Systems, devices, and methods for transdermal delivery." This patent discloses systems and devices designed for the transdermal delivery of therapeutic agents to specific therapy sites. The technology is flexible, allowing it to conform to various contours, such as the shape of a user's face. The devices include an integrated power supply for standalone application, enhancing their usability. Additionally, the systems feature flexible electrodes with integrated conductance layers, which improve stability and current distribution. The device operates by electrically coupling at least two electrodes to the therapy site, drawing current from the power supply to deliver the therapeutic agent effectively.

Career Highlights

Christopher A. Hobson is associated with Iontera, Inc., where he continues to develop innovative solutions in the field of transdermal delivery. His work has positioned him as a key figure in advancing therapeutic technologies.

Collaborations

Hobson collaborates with notable professionals in his field, including Michael K. Jordan and Miaoyong Cao. These collaborations enhance the development and application of his innovative technologies.

Conclusion

Christopher A. Hobson's contributions to transdermal delivery systems exemplify the impact of innovation in healthcare. His patent and ongoing work at Iontera, Inc. highlight his dedication to improving therapeutic methods for better patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…